Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

NCT02493764 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

537

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Pneumonia

Interventions

DRUG: Imipenem
DRUG: Relebactam
DRUG: Cilastatin
DRUG: Piperacillin
DRUG: Tazobactam
DRUG: Linezolid

Sponsor

Merck Sharp & Dohme LLC